How to tell the difference between normal/abnormal biomarkers; Knome aids Parkinson's discovery

> It is difficult to distinguish the difference between biomarkers that indicate disease and those that occur when everything is normal. New research sheds light on how to tell the difference. NPL release

> Cambridge, MA-based genomics company Knome says its technology helped in the discovery of a Parkinson's biomarker. Report

> Researchers find a two-for-one gene that could cause both Alzheimer's and Type 2 diabetes. Mount Sinai release

> Biomarkers may predict the likelihood of miscarriage, according to a British researcher. Article

> Researchers at Oxford University are seeking female volunteers to participate in a research study looking at potential markers in endometriosis. More information

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.